title: Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice.
abstract: Interleukin-2 (IL-2) plays a pivotal role in the cellular and humoral immune responses directed against foreign antigens. We characterized the in vitro and in vivo properties of a chimeric protein consisting of mouse IL-2 fused to the mouse IgG2b Fc domains. This fusion protein binds to IL-2 and Fc receptors and supports IL-2-dependent cell proliferation but does not mediate lysis of IL-2 receptor-positive cells in the presence of murine complement in vitro. However, in vivo the IL2-IgG2b fusion protein suppresses both cellular and humoral immune responses after immunization with sheep erythrocytes. Surprisingly, delayed hypersensitivity is inhibited despite a dramatic increase of splenic CD3+ and NK1.1+ lymphocytes, indicating that altered homing of IL2-IgG2b-activated lymphocytes rather than cytolysis prevents these cells from accumulating in areas of inflammation. Although in vitro the IL2-IgG2b fusion protein does not alter proliferation of B cells in response to mitogenic stimulation, IgM production in response to sheep erythrocytes is profoundly inhibited in mice treated with the IL2-IgG2b fusion protein. Since no side effects are observed, the IL2-IgG2b fusion protein may expand the therapeutic repertoire of reagents used for the treatment of allograft rejection and autoimmune diseases.
authors.affiliation: Institute of Immunology, Universitätsklinikum Benjamin Franklin, Berlin, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Kunzendorf
authors.forename: T
authors.initials: T
authors.lastname: Pohl
authors.forename: S
authors.initials: S
authors.lastname: Bulfone-Paus
authors.forename: H
authors.initials: H
authors.lastname: Krause
authors.forename: M
authors.initials: M
authors.lastname: Notter
authors.forename: A
authors.initials: A
authors.lastname: Onu
authors.forename: G
authors.initials: G
authors.lastname: Walz
authors.forename: T
authors.initials: T
authors.lastname: Diamantstein
mesh_terms: D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D005260:Female; D006968:Hypersensitivity, Delayed; D007074:Immunoglobulin G / Q000378:metabolism / Q000494:pharmacology*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D007376:Interleukin-2 / Q000378:metabolism / Q000494:pharmacology*; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D011993:Recombinant Fusion Proteins / Q000494:pharmacology*
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins